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Abstract
Synaptic activity in the central nervous system undergoes rapid state-dependent changes, requiring constant adaptation of
the homeostasis between excitation and inhibition. The underlying mechanisms are, however, largely unclear. Chronic
changes in network activity result in enhanced production of the inhibitory transmitter GABA, indicating that presynaptic
GABA content is a variable parameter for homeostatic plasticity. Here we tested whether such changes in inhibitory
transmitter content do also occur at the fast time scale required to ensure inhibition-excitation-homeostasis in dynamic
cortical networks. We found that intense stimulation of afferent fibers in the CA1 region of mouse hippocampal slices
yielded a rapid and lasting increase in quantal size of miniature inhibitory postsynaptic currents. This potentiation was
mediated by the uptake of GABA and glutamate into presynaptic endings of inhibitory interneurons (the latter serving as
precursor for the synthesis of GABA). Thus, enhanced release of inhibitory and excitatory transmitters from active networks
leads to enhanced presynaptic GABA content. Thereby, inhibitory efficacy follows local neuronal activity, constituting a
negative feedback loop and providing a mechanism for rapid homeostatic scaling in cortical circuits.
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Introduction
For proper information processing, the overall level of activity in
neuronal networks has to be maintained within a physiological
range between total silence and over-excitation, as it occurs within
epileptic seizures. This functional homeostasis is reflected in
network architecture which typically includes negative feedback by
inhibitory interneurons, limiting the activity of excitatory neurons.
However, the functional state of most central neuronal networks is
highly dynamic, causing rapid changes in neuronal firing patterns,
overall activity, and synchrony [1]. At the same time, associative
memory mechanisms induce activity-dependent changes in
synaptic weights. Therefore, homeostatic mechanisms must exist
which adapt the balance between excitation and inhibition to the
rapidly changing activity in the networks [2]. Indeed, homeostatic
plasticity has been demonstrated at the level of intrinsic neuronal
properties [3] and synaptic strength [4,5]. The underlying
mechanisms are, however, far less understood than classical
Hebbian forms of plasticity.
Following prolonged periods of altered network activity, inter-
neurons can alter the amount of GABA which is released for
inhibitory synaptic transmission. For example, increased expression
of the GABA-synthesizing enzyme glutamate decarboxylase (GAD)
has been found in the hippocampus of chronically epileptic rats [6].
Conversely, GABA is down-regulated in deafferentiated somatosen-
sory projection areas [7]. Under physiological conditions, one
isoform of GAD (GAD65) is involved in defining critical period
plasticity in the visual cortex [8]. Together, these findings suggest
that the production of GABA contributes to homeostatic plasticity in
neuronal networks. Consistent with this idea, recent evidence shows
thatchangesinpresynapticGABAcontentdoindeedalterinhibitory
efficacy [4,9–11]. It is unclear, however, whether this mechanism is
alsooperant upon rapid changes of activity aspresent indynamically
changing networks. A possible mechanism for such activity-
dependent, rapid adaptation is uptake of transmitters from the
extracellular space. Axon terminals of inhibitory interneurons are
equipped with membrane-bound uptakesystemsforGABA [12]and
forglutamate[13,14].GABAcanthenbedirectlyusedforrefillingof
vesicles, while Glutamat is converted into GABA within the
presynaptic bouton [15–17].
We hypothesized that uptake-mediated changes in presynaptic
transmitter content can account for homeostatic scaling of
GABAergic transmission upon rapid changes in network activity.
This hypothesis requires i) that enhanced synaptic activity does
enhance extracellular levels of GABA and glutamate; ii) that these
transmitter molecules are rapidly and efficiently taken up by axon
terminals of interneurons; iii) that the resulting cytosolic increase in
GABA is sufficient to enhance filling of vesicles; and iv) that vesicles
with enhanced GABA content cause significantly larger postsynaptic
currents. In the present study tetanic stimulation of afferent fibers in
the CA1 region of mouse hippocampal slices yielded a rapid and
lasting increase in quantal size of miniature inhibitory postsynaptic
currents. This potentiation is mediated by the release of larger
quanta of GABA and can be blocked by combined inhibition of
glutamate- and GABA-uptake. Thus, transmitters can be taken up
from the extracellular space in an activity-dependent manner and
are used to boost inhibitory synaptic efficacy. These findings provide
a mechanism for rapid homeostatic scaling in cortical circuits,
constituting a negative feedback loop between network activity and
inhibitory synaptic efficacy.
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Up-scaling of GABAergic transmission following
enhanced synaptic activity
We tested the idea that hippocampal interneurons homeostat-
ically scale the strength of GABAA-mediated synaptic transmission
as a function of local synaptic activity. We therefore applied high-
frequency electrical stimulation to stratum radiatum of mouse
hippocampal slices and recorded inhibitory synaptic activity from
CA1 pyramidal cells in whole-cell configuration (see methods).
Ionotropic glutamate receptors were blocked throughout in order
to isolate GABAergic postsynaptic currents (IPSCs) and to avoid
classical glutamate-mediated mechanisms of plasticity. Changes in
inhibitory efficacy were measured at the level of single presynaptic
vesicles by recording miniature IPSCs (mIPSCs) in the presence of
TTX.
In CA1 pyramidal cells from unstimulated control slices we
found a broad distribution of mIPSC amplitudes with a median
quantal amplitude of 15.760.8 pA at 270 mV (n=7; based on
18906291 events/cell within the 10 min interval of evaluation).
Amplitude and frequency of mIPSCs remained stable within a
recording period of ,60 min (Fig. 1A; Fig. 2B). In stimulated
slices, network activity was enhanced by afferent stimulation
immediately before application of TTX and recording of mIPSCs.
This procedure resulted in enlarged mIPSCs (Fig. 1A), as
confirmed by a clear rightward shift of the cumulative amplitude
probability plot (Fig. 1B). For quantification, we analyzed median
amplitudes of mIPSC distributions from 7 control cells and 9
stimulated cells, yielding a potentiation by ,70% (median
amplitude during the first 10 min after stimulation: 26.162.6
pA; n=9; based on 31556830 events/cell within 10 min). This
increase in unitary amplitudes lasted for about 40 minutes before
Figure 1. Increased miniature IPSC amplitudes following afferent fiber stimulation. (A) Original recordings of mIPSCs without (left) and
with (right) afferent stimulation at 100 Hz for 1 s. Arrowheads indicate wash in of TTX and time of stimulation. Bottom traces show enlarged sections
from long-lasting recordings illustrated above. Note apparent increase of amplitudes following stimulation. (B) Cumulative amplitude histograms
from the experiments shown in A (data taken from the first 10 min after stimulation). Note shift towards larger amplitudes after stimulation (p,0.05;
Kolmogorov-Smirnov test). (C) Median amplitudes of mIPSCs in cells from non-stimulated (black) and stimulated (open bars) slices for the recording
period of 60 minutes. Significant increase of median amplitudes at 0 to 40 minutes after stimulation (n=7 cells (control) and 9 cells (stimulated);
p,0.05). (D) Normalized amplitude distribution of mIPSCs from control cells (black line) and stimulated cells (grey line). Note increased relative
frequency of events with amplitudes .30 pA following stimulation. (E) Analysis of the first 100 s of recording after block of action potentials (20 s
after stimulation). Open circles indicate median mIPSC amplitudes following stimulation which are increased from the earliest intervals analyzed
(p,0.001, Wilcoxon matched pairs).
doi:10.1371/journal.pone.0002979.g001
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amplitude histograms revealed that there was a pronounced
increase in the proportion of medium-sized mIPSCs, whereas the
number of large events or their absolute amplitude were not
significantly enhanced (Fig 1D; Fig. 3D). Onset of this form of
synaptic plasticity was fast. A detailed analysis of the initial phase
revealed that the effect was already fully established at ,20 s after
stimulation (Fig. 1E). Thus, unitary inhibitory strength adapts
rapidly to enhanced synaptic activity in the CA1 network.
While afferent stimulation caused a fast and sustained increase
in mIPSC amplitudes, event frequency was less affected. Inter-
event intervals of mIPSCs appeared slightly reduced after afferent
stimulation, but were not significantly altered (Fig. 2A). A
complicating factor in the assessment of mIPSC frequency is the
signal-to-noise ratio which may change following altered network
activity, causing systematic errors in event counts. In our cells,
baseline noise was not different between unstimulated and
stimulated slices (5.361.1 pA unstimulated vs. 6.660.9 pA;
Fig. 2C, D). Together with the unchanged input- and series
resistance (Fig. 2B), this finding does largely exclude that
differences in event detection underlie the observed effects. It also
suggests that afferent stimulation does not cause a lasting increase
in tonic inhibition. Thus, enhanced synaptic activity in CA1 causes
an increase of quantal IPSC amplitudes in pyramidal cells without
gross changes in event frequency.
Presynaptic location of activity-induced changes
Changes in quantal size are traditionally explained by changes
in postsynaptic responsiveness. Recent evidence indicates, howev-
er, that presynaptic vesicular transmitter content can also account
for changes of mIPSC amplitudes [9,10]. We therefore sought to
identify the primary site of adaptation. First, we analyzed the
kinetics of postsynaptic currents. Decay time course could be well
approximated by monoexponential fits and revealed similar time
constants for cells from unstimulated and stimulated slices,
respectively (15.5463.22 ms vs. 16.2262.99 ms; Fig 3A, B). In
contrast, the rising phase of events was significantly steeper
following afferent stimulation (61.764.6 pA/ms versus 49.963.4
pA/ms; p,0.05; Fig. 3B), consistent with larger amounts of GABA
being released [18]. Second, we calculated the coefficient of
variance of mIPSC amplitudes which was significantly reduced in
cells which underwent afferent stimulation (control: 0.7360.15;
stimulated: 0.6260.11; p,0.01; Fig. 3C). Thus, mIPSC ampli-
tudes became more homogeneous, consistent with a more
homogeneously filled population of presynaptic vesicles [19].
Third, we checked whether the potentiation reaches a ceiling level
for large mIPSCs. Taking the 10 largest mIPSCs from each cell we
found no significant potentiation by afferent stimulation, in
contrast to the whole population of events (Fig. 3D). Thus,
potentiation was restricted to vesicles and synaptic sites with sub-
saturating amounts of GABA. Fourth, we checked directly for
Figure 2. Stability of recording conditions. (A) Median inter-event intervals of mIPSCs in control (filled circles) and stimulated cells (open
circles). Apparent decrease in intervals does not reach significance. (B) Median mIPSC amplitudes from control and stimulated cells (filled and open
circles, respectively) are not correlated with series resistance during the recording period of 1 h (black line: mean Rs in control cells; grey line: mean Rs
in stimulated cells). Values averaged for 5-min intervals. (C) Gaussian distribution of membrane noise from two representative cells (half-width 6.9 pA
control and 6.5 pA stimulated). All-point histograms taken from 3 s of event-free raw data. (D) Mean baseline noise is similar for control cells and cells
following afferent stimulation (5.361.1 pA, n=6 versus 6.660.9 pA, n=8).
doi:10.1371/journal.pone.0002979.g002
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therefore used laser-flash photolysis of CNB-caged GABA (20 mM)
for rapid activation of postsynaptic GABAAR before and after
stimulation, respectively. Flashing onto the somatic membrane
reliably caused inward currents with rapid rise and slower decay
(Fig. 4A). The resulting GABAergic currents were similar in both
conditions (peakamplitude59.8615.2 pA priortostimulation versus
62.2616.9 pA after stimulation, respectively; n=9; Fig. 4B). While
this approach may inducecurrentswith an enhanced contribution of
extrasynaptic receptors, it supports the notion that the postsynaptic
responsiveness of GABAA receptors was unchanged.
We also tested for the effect of the weak GABAA receptor
antagonist TPMPA. This drug reduces IPSC amplitudes but has
lower efficacy when saturation of postsynaptic GABAA receptors is
high[4,11,20].Inbothgroupsofcells,additionofTPMPA(200 mM)
reduced the number of detectable events to ,50% of control (data
not shown). TPMPA was applied to the bath at 10 min following
stimulation or at the corresponding time in non-stimulated neurons.
We then calculated the change in amplitude distribution induced by
TPMPA in each cell (Fig. 4C). The resulting histograms show a clear
shift towards medium-sized events, at the expense of very small and
very large mIPSCs. Moreover, this effect was more pronounced in
stimulated than in non-stimulated neurons as indicated by the
rightward shift of event counts in Fig. 4C (p,0.0001, Wilcoxon
matched-pairs signed-ranks test). Median mIPSC amplitudes,
however, were not differentially affected by TPMPA (Fig. 4D).
Thus, increased synaptic activity potentiates mIPSCs without
affecting events with very large amplitude. Together with the faster
mIPSC rise time, differential effect of TPMPA and unchanged
postsynaptic GABA-sensitivity these findings are best compatible
with an increase in vesicular GABA content, yielding a more
homogeneous distribution of GABAergic vesicles.
Transmitter uptake as a source of vesicular filling
In order to unravel the mechanisms underlying the increased
quantal size, we sequentially blocked different sources of substrate
supply for vesicular GABA filling. One major pathway is provided
by the neuronal plasma membrane GABA transporter GAT-1
[21]. We therefore applied the GAT-1-selective GABA uptake
blocker NNC-711 (10 mM) immediately after stimulation. As
expected, the prolonged presence of GABA in the synaptic cleft
slowed the decay time course of mIPSCs (Fig. 5A). NNC-711
reduced the stimulation-induced potentiation of mIPSC ampli-
tudes. Median amplitude at 10 min post-stimulation was 20.262.4
pA as compared to 26.162.6 pA in drug-free potentiated slices
and of 15.760.8 pA in control cells (Fig. 5E). While the apparent
change in median mIPSC amplitude by NNC-711 was not
significant, the amplitude distribution was clearly shifted to values
between control and stimulated cells (Fig. 5B). Comparison of
averaged cumulative amplitude distributions revealed that NNC-
711 diminished the stimulus-induced potentiation (p,0.05;
Kolmogorov-Smirnov test). The mIPSCs were, however, still
larger than in non-stimulated controls (p,0.01, Kolmogorov-
Smirnov test). Thus, the activity-dependent potentiation of
mIPSCs depends partially, but not exclusively, on GABA uptake.
Recent evidence shows that uptake of glutamate can serve as an
alternative source for vesicular GABA [10,22]. Glutamate is taken
up into presynaptic terminals of GABAergic neurons by the
transporter EAAC1 [8,9] where GABA can be synthesized by
GAD65 [17]. Therefore, we repeated the experiment in the
presence of TBOA (100 mM), a blocker of the neuronal plasma
membrane glutamate transporter EAAC1. TBOA blunted the
stimulation-induced rise in median mIPSC amplitude (at 10 min
post-stimulation: 23.560.9 pA; Fig. 5 A, E). Similar to the effect of
the GABA uptake-blocker, median values of mIPSC amplitudes
Figure 3. Properties of potentiated mIPSCs. (A) Averaged waveform of control and post-stimulation mIPSCs, taken from two representative
example cells. Note steeper onset of the events in stimulated cell (dotted lines show linear fits to the 20–80% portion of the rising phase). (B) Decay
time constants (left bars, mean6s.e.m.) are unchanged in stimulated cells while rate of rise (right bars) is significantly increased. (C) Coefficient of
variance of mIPSC amplitudes is decreased after stimulation. Data taken from the first 10 min interval after application of TTX; n=22 unstimulated
cells and n=19 cells after afferent stimulation. Boxes show mean value, 25 and 75% confidence intervals, and s.e.m., respectively. (D) Potentiation
depends on quantal size. Left bars show the ,70% increase in median amplitude when all detected mIPSCs are counted within the first 10 min after
washin of TTX (p,0.05). Right bars (hatched) show the median amplitudes of the 10 largest mIPSCs from each cell. The apparent amplitude increase
by ,26% is not significant.
doi:10.1371/journal.pone.0002979.g003
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cells or drug-free stimulated cells (Fig. 5 E). However, cumulative
amplitude histograms were again located between those from
controls and from stimulated cells (Fig. 5C). Similar to NNC-711,
averaged cumulative amplitude distributions were significantly
different from both control (p,0.001; Kolmogorov-Smirnov test)
and stimulated cells (p,0.02; Kolmogorov-Smirnov test). These
data demonstrate a contribution of glutamate uptake to the
activity-dependent plasticity of inhibition. However, EAAC1 can
not fully account for the potentiating effect of stimulation.
Consequently, we combined both drugs to block GABA- as well
as glutamate-uptake immediately after stimulation. In this
situation, activation of afferent fibers failed to induce an increase
in quantal size of mIPSCs (Fig. 5 A,E; median at 10 min 17.460.9
pA for stimulated cells versus 15.760.8 pA for controls;
significantly different from amplitudes in drug-free stimulated
slices; p,0.05). Accordingly, the respective cumulative amplitude
distribution plot overlaps with that from control experiments
(Fig. 5D). On average, cumulative distributions in the presence of
both uptake blockers were similar to those of control cells (p.0.1,
Kolmogorov-Smirnov test) but different from stimulated cells
(p,0.001; Kolmogorov-Smirnov test). Median amplitude changes
in the absence and presence of GABA- and glutamate-uptake
inhibitors are summarized in Figs. 5E and 5F.
These data show that membrane transporters for GABA and for
glutamate are both critically involved inthe observed potentiation.A
parsimonious explanation for our findings is that afferent stimulation
causes a transient increase in extracellular levels of GABA and
glutamate which are rapidly taken up into presynaptic terminals of
interneurons. Alternatively, it is feasible that stimulation directly
increases the efficacy of GAT-1 and EAAC1 which would also lead
to increased presynaptic transmitter content. We tested for this
possibility by delayed application of NNC-711 and TBOA after
establishing the initial mIPSC potentiation. This delayed block of
transmitter uptake should de-potentiate mIPSCs if enhanced activity
of the transporters was required throughout the maintenance of the
effect.However,thiswasnotfoundexperimentally.Incontrasttothe
application of uptake-blockers immediately after stimulation
(Fig. 5E), delayed application of the drugs at 10 min after the
stimulation did not reverse the initially established potentiation
(23.461.5 pA versus 26.162.6 pA, with and without blockers,
respectively; Fig. 5G). These data exclude that a lasting potentiation
of the transmitter transporters themselves contributes to the
potentiating effect of afferent stimulation. They are rather consistent
with uptake of the transmitters immediately after the stimulus which
increases extracellular concentrations of GABA and glutamate.
Thereby, transmitter uptake by GAT-1 and EAAC1 provides a
direct coupling between actual network activity and inhibitory
synaptic strength. The persistent potentiation upon late application
of NNC-711 and TBOA does also rule out that the block of
potentiation by early application of uptake-inhibitors is caused by
receptor desensitization through enhanced extracellular levels of
GABA or glutamate.
An alternative explanation for an activity-dependent increase in
mIPSC amplitude is uptake of glutamate by glia cells, conversion
into glutamine and export into terminals of interneurons
Figure 4. (A) Averaged example traces (n=10) of GABA responses following UV-light induced uncaging of GABA. Black and grey lines
show responses before and after afferent stimulation, respectively. (B) Similar amplitudes of GABA-induced currents before and after stimulation.
Data from 9 cells, showing no significant difference in postsynaptic GABA sensitivity. (C) Differences in normalized amplitude distribution of mIPSCs
induced by TPMPA (200 mM). Black line: control cells; grey line: potentiated cells. In both groups of cells, relative frequency of events with medium
amplitude is increased, while small and large events are less frequent. This effect is different between stimulated and control cells, respectively
(p,0.0001, Wilcoxon matched-pairs signed-ranks test). (D) Supression of median amplitude by TPMPA. No significant difference was observed
between control (n=6) and stimulated cells (n=6), respectively.
doi:10.1371/journal.pone.0002979.g004
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occur in the presence of the system A transport blocker MeAIB
(5 mM, applied 5 min prior to stimulation; median 23.260.6 pA,
n=3; p.0.1 towards stimulated drug-free cells; Kolmogorov-
Smirnov test). These data suggest that glutamine uptake is not a
major source of additional GABA in the present form of plasticity.
Figure 5. Prevention of mIPSC amplitude potentiation by blockers of GABA- and glutamate-uptake. (A) Averaged mIPSCs (n=200
each) from representative cells recorded under control conditions; after stimulation; stimulation+NNC-711 (10 mM); stimulation+TBOA (100 mM);
stimulation+NNC-711+TBOA. (B) Effect of NNC-711 (solid line) illustrated by cumulative amplitude distribution curves of the cells depicted in A. Curve
is situated between distributions from control (left) and drug-free stimulated cell (right; dashed lines; data from Fig. 1A, B). (C) Effect of TBOA (solid
line) for cell shown in A. Note shift towards larger amplitudes against control and smaller amplitudes against drug-free stimulated cell (dashed lines
as in C). (D) Block of mIPSC potentiation in the presence of both uptake blockers (solid line). Note overlap of cumulative amplitude distribution with
control data. (E) Summary of pharmacological experiments (mean6s.e.m. of relative median amplitude values, control cells=100%). Numbers of
cells: 7 control; 9 stimulated; 5 stimulated+NNC-711; 8 stimulated+TBOA; 7+NNC-711+TBOA. (F) Time course of median mIPSC amplitudes over
60 minutes of recording, analyzed in intervals of 10 min. Note the stability of control amplitudes (grey trace, bottom). Stimulation-induced amplitude
increase decreases slowly over 60 min and is reduced by the application of NNC-711 (green trace) or by TBOA (red trace). Note complete loss of
potentiation after combined application of NNC-711 and TBOA (blue trace). (G) Delayed application of uptake-blockers does not prevent or revert
potentiation. Bar diagrams show means of median amplitudes. Note persistent potentiation after delayed application of NNC-711 and TBOA (at
10 min after establishing the activity-dependent potentiation).
doi:10.1371/journal.pone.0002979.g005
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As an independent test for the contribution of vesicular filling to
the scaling of GABAergic synaptic strength we made use of the fact
that most released glutamate is buffered by uptake into glia cells
[25]. Suppression of this pathway should therefore divert
glutamate from astrocytes to neurons, facilitating uptake of the
GABA-precursor into inhibitory terminals. Application of the
GLT-1 blocker dihydrokainate (DHK) without additional synaptic
stimulation did indeed induce a continuous, slowly developing
increase in mIPSC amplitude. Potentiation became significant
after 30 min in 3/4 cells (Kolmogorov-Smirnov test; p,0.05) and
reached 122.868.5% of control after 60 minutes (Fig. 6A, C;
n=4). This effect could be reversed by subsequent application of
TBOA (Fig. 6D). This finding underlines the importance of
neuronal glutamate uptake for GABAergic efficacy.
Finally, we reversed our experimental approach, trying to
reduce vesicular GABA filling by blocking uptake of both
transmitters. Simultaneous application of TBOA and NNC-711
reduced mIPSC amplitudes progressively over 60 minutes,
reaching 80.267.0% of control (Fig. 6B, C; n=4). The leftward
shift of cumulative amplitude distributions became significant after
40 min in 3/4 cells (Kolmogorov-Smirnov test; p,0.05). Thus,
uptake of transmitters from the extracellular space is crucial for the
maintenance of inhibitory efficacy even under conditions of low
synaptic activity in the hippocampal network.
Discussion
Homeostatic plasticity through regulation of transmitter
content
Our findings reveal that GABAergicsynapses can rapidly adapt to
changes in local network activity by changing vesicular transmitter
content. Enhanced synaptic release of GABA and glutamate from
endogenous stores is sufficient to boost the GABA content of
inhibitory terminals. This effect is mediated by GABA- and
glutamate-transporters which are both present at GABAergic
synapses, allowing for fast adaptation of inhibition without a need
for de novo protein synthesis or -transport (Fig. 7). Uptake-mediated
plasticityprovidesadirectcouplingbetweenextracellulartransmitter
concentration and inhibitory synaptic strength. We show that the
potentiationoccursuponasingletetanicstimulationofafferentfibers
and exerts full efficacy within seconds. This mechanism constitutes a
negative feedback loop which can stabilize excitation-inhibition-
balance under conditions of dynamic network functions.
The potentiation of mIPSCs by uptake of previously released
GABA and glutamate is likely to occur preferentially close to
synapses which have been particularly active. There is a vast
variety of GABAergic interneurons which project to defined
laminar positions at CA1 pyramidal cells [26]. Thus, the effect will
be most pronounced at specific sites of the target cells, providing
an input-specific homeostasis of excitation and inhibition. In our
somatic recordings, GABAergic mIPSCs were measured regard-
less of the site of the releasing terminal, probably leading to an
underestimation of the local effect at the sites of release. Future
analysis with recordings from pairs of pre- and postsynaptic cells or
highly localized induction of transmitter release will be needed to
resolve the role of defined subpopulations of interneurons for
uptake-mediated homeostasis.
The stimulation protocol used in our approach is similar to
conventional methods of LTP induction at Schaffer collateral
synapses but was performed in the presence of blockers of
ionotropic glutamate receptors. This rules out that the observed
effects on synaptic inhibition are mediated by conventional
NMDA-dependent plasticity at Schaffer collateral synapses.
Figure 6. Alteration of miniature IPSC amplitudes without additional stimulation. (A) Successive mIPSC cumulative amplitude
distributions at 0, 40, 50, 60 min from a cell in the presence of DHK (300 mM). Significant rightward shift after 40 min. (B) Successive mIPSC amplitude
distributions in the presence of NNC-711 and TBOA. Significant leftward shift after 0, 40, 50, 60 min. (C) Changes in median amplitudes
(mean6s.e.m.) of unstimulated cells after block of glial glutamate-uptake (left; 60 min in DHK; n=4) and after block of neuronal GABA- and
glutamate-uptake (right; 60 min in NNC-711+TBOA; n=4). (D) Increase of median amplitude under DHK in two cells is reversed by addition of the
neuronal glutamate uptake blocker TBOA.
doi:10.1371/journal.pone.0002979.g006
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release of further agents like serotonin, BDNF and others may well
be present but cannot account for the immediate amplitude
increase of miniature IPSCs which was fully blocked by combined
inhibition of GABA- and glutamate-uptake, respectively.
Another confounding factor may be a change in release
probability of GABAergic vesicles which may result in synchro-
nous exocytosis of multiple vesicles from the same release site [27].
This effect is unlikely to underlie the present observations: there
was no indication for any secondary peaks in quantal amplitude
distributions, rise time of mIPSCs was shortened without
indication for increased occurrence of events with multiple onset
kinetics, and the potentiation was sensitive towards blockers of
transmitter uptake which interfere with vesicular filling, rather
than with release probability.
GABA and glutamate transporters determine inhibitory
strength
Most likely, GABA is taken up into the same terminal from
which it has been released. Thereby, resting vesicles gain
additional GABA from the content of previously released vesicles.
GABAergic synapses in the hippocampus express GAT-1, a
membrane-located high-affinity transporter of GABA [28]. A well-
established function of the GABA transporter is to limit the
duration of postsynaptic receptor activation at inhibitory synapses
[29,30]. However, it may also be essential for filling the
presynaptic terminals with GABA, consistent with the epileptic
phenotype of GAT-1-deficient mice [31] and with our present
data. Blocking GABA uptake or suppressing the expression of
GAT-1 has diverse cellular and systemic effects [32,33], possibly
due to the overlapping effects of reduced GABA supply, enhanced
tonic inhibition [31,34] and prolonged duration of inhibitory
postsynaptic potentials [29]. Our present data confirm that
GABA-uptake is an essential source for vesicular filling in active
hippocampal circuits. Glutamate, on the other hand, can spill over
from neighboring synapses [35,36], providing a genuine addition
to the transmitter pool. We found that part of the activity-
dependent potentiation is blocked by TBOA, an inhibitor of the
neuronal glutamate transporter EAAC1. Hippocampal interneu-
rons express EAAC1 at their axon terminals [13,14]. In stratum
radiatum of CA1, these presynaptic terminals are localized in close
vicinity to excitatory synapses [37]. Once taken up, glutamate is
converted into GABA by GAD65, which resides in GABAergic
terminals [15] and interacts directly with the vesicular GABA
transporter VGAT [16,17]. Consistent with this hypothesis, direct
application of glutamate into hippocampal slices increases the
amplitude of inhibitory postsynaptic currents [10]. Conversely,
reduced expression of EAAC1 decreases IPSC amplitude and
causes epileptic seizures [22]. Using stimulation-induced release of
GABA and glutamate from endogenous stores, we have observed
an activity-dependent increase in mIPSC amplitude which was
fully blocked by combined inhibition of GAT-1 and EAAC1. Our
findings thus suggest that a brief increase in transmitter release
does supply sufficient GABA and glutamate to yield a rapid and
lasting increase in quantal size of mIPSCs. This shows that the
terminals of inhibitory neurons are highly sensitive and rapidly
acting detectors for extracellular transmitters [38,39], making
presynaptic transmitter uptake a crucial element in homeostatic
plasticity of hippocampal networks.
An alternative source for GABA is glutamine. While inhibitory
axon terminals do not express appreciable amounts of glutamine-
transporters and lack the glutamine-converting enzyme GLS1
[40,41], recent evidence points towards a role for maintaining basal
GABA levels at somato-dendritic sites [23,24], or for activity-
dependent regulation of vesicular GABA content by glutamine [11].
In our experimental approach, application of the system A transport
inhibitor MeAIB [23] did not abolish the potentiating effect of
afferent stimulation. Moreover, application of DHK is expected to
reduce glial glutamate-glutamine conversion, probably resulting in
lower glutamine-uptake by interneuron terminals. We found
increased mIPSC amplitudes under these conditions, indicating that
export of glutamine from glia cells is not a major limiting factor in
our system. This does, however, not exclude a role for glutamine in
the maintenance of basal GABA levels [23,24] or in GABAergic
transmission under conditions of increased activity [11].
Activity-dependent vesicular filling determines quantal
size
The observed increase in mIPSCs depends on two crucial
prerequisites: first, that vesicles are not filled with saturating
amounts of GABA, and, second, that non-potentiated vesicles are
sub-saturating for postsynaptic GABAA receptors. Although initial
experimental and theoretical analysis of quantal inhibitory
transmission in dentate granule cells revealed indication for
postsynaptic saturation [42], several subsequent studies showed
that unitary events of transmitter release are sub-saturating at
inhibitory synapses in other regions, including CA1: It has been
shown that the variable GABA content of presynaptic vesicles
contributes to the variance of mIPSC amplitudes [19]. Increasing
presynaptic GABA content by block of GABA-degradation does
increase mIPSC amplitudes in CA3 pyramidal cells, supporting
the view that vesicular GABA content and postsynaptic receptor
occupancy are normally not saturated [9]. Similar findings have
been made for glutamatergic synapses [43], neuromuscular
junctions [44], and for dopaminergic synapses in midbrain
neurons [45]. An independent proof for sub-saturating synaptic
GABA concentrations at CA1 pyramidal neurons is provided by
the potentiating effect of benzodiazepines at these synapses.
Several observations show that these agents, which increase
agonist affinity of GABAA receptors, can potentiate the amplitude
Figure 7. Schematic representation of the molecular scaling
mechanism at inhibitory terminals. GABA is taken up through the
neuronal GABA transporter GAT-1. In addition, glutamate is transported
into the terminal by EAAC1. Subsequently, glutamate is converted into
GABA by GAD65 which is directly coupled to the vesicular GABA
transporter VIAAT. Both mechanisms modulate vesicular filling,
depending on synaptic activity in the local environment. Glial
glutamate transport is mediated by two different isoforms, GLT1 and
GLAST. Reduction of glial glutamate uptake by the GLT1-blocker
dihydrokainate (DHK) diverts glutamate into neuronal terminals,
increasing vesicular GABA filling.
doi:10.1371/journal.pone.0002979.g007
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explained by the additional activation of a receptor ‘‘reserve’’
[46,47], although the major effect of benzodiazepines may be due
to the prolongation of postsynaptic responses [48]. Similarly,
increased uptake of glutamine results in increased amplitudes of
evoked IPSCs in CA1, confirming the net increase in inhibitory
efficacy upon enhanced vesicular GABA content [11].
Thus, inhibitory synapses in CA1 leave room for enhanced
amplitudes after release of GABA-enriched vesicles. Recent
experiments on inhibitory synapses with lowered GABA content
found an increased efficacy of the weak competitive GABAA
receptor antagonist TPMPA [4,11]. In our approach, GABA levels
were enhanced, rather than decreased. Therefore, TPMPA
induced different changes in amplitude distributions of control
and stimulated cells, leaving more events with relatively large
amplitudes in the latter. This finding is well compatible with
increased transmitter content in a fraction of GABAergic vesicles
following stimulation. The net effect on median mIPSC amplitude,
however, was not different, probably reflecting the dilution of the
effect by sampling from all (including non-potentiated) synapses
and the confounding suppression of certain GABAA receptor
isoforms in CA1 pyramidal cells by TPMPA [49]. The finding that
TPMPA induces a pronounced increase in medium-sized mIPSCs
indicates that GABA content was preferentially enhanced in
vesicles with low initial transmitter content. Possibly, highly loaded
vesicles show saturation due to the decreasing electrochemical
gradient at vesicular membranes [50]. Therefore, potentiation by
enhanced transmitter release leads to a redistribution of vesicles,
favoring those with medium, but sub-saturating GABA content.
Non-Hebbian plasticity underlies network homeostasis
Rapid scaling of inhibitory synaptic efficacy is necessary for
stable information transfer during Hebbian plasticity. In addition,
multiple observations point towards non-Hebbian, homeostatic
adaptations of inhibition during developmental [8], activity-
dependent [3,5] and pathophysiological plasticity [6,7]. The
present data show that excitation/inhibition-balance can be
rapidly adjusted to the needs of the local network by linking the
filling of GABAergic vesicles to acute changes in extracellular
levels of synaptically released GABA and glutamate. Thereby,
inhibitory quantal efficacy is coupled to local network activity,
providing a fast negative feedback loop for homeostatic plasticity.
This mechanism may also be relevant for the pathophysiology of
epilepsy where prolonged periods of enhanced synaptic activity
may increase vesicular GABA content, thereby contributing to
spontaneous seizure arrest.
Methods
Hippocampal slice preparation
All animal procedures were approved by the state government
of Baden-Wu ¨rttemberg and are in accordance with NIH
guidelines. Experiments were performed on horizontal slices of
the hippocampus (300 mm in thickness), prepared from young
adult male C57Bl6 mice (.4 weeks) in ice cold sucrose solution
which contained (in mM): sucrose 75; NaCl 87; KCl 2.5;
NaH2PO4 1.25; NaHCO3 26; MgCl2 7; CaCl2 0.5; glucose 25,
saturated with 95%O2-5%CO2. Subsequently, slices were incu-
bated for 30 min in a submerged chamber at 34uC, followed by
storage at RT in artificial cerebro-spinal fluid (aCSF) containing
(in mM): NaCl 124; KCl 3; NaH2PO4 1.25; NaHCO3 26; MgSO2
1.8; CaCl2 1.6; glucose 10, saturated with 95%O2-5%CO2,
pH 7.3 for 1–5 h before being placed in the submerged recording
chamber.
Whole cell recordings
Whole cell patch-clamp recordings were performed at RT on
visually identified CA1 pyramidal neurons continuously super-
fused with aCSF. Pipette resistance was 2–5 MV, leading to series
resistances of 8–16 MV which were controlled regularly every
5 min throughout the experiment. Currents were recorded in
voltage clamp condition at 270 mV in symmetrical chloride (KCl-
based intracellular solution; in mM: KCl 120; NaCl 5; CaCl2 0.5;
MgCl2 2; HEPES 10; EGTA 5; pH 7.25; 285 mOsmol).
All drugs were obtained from Tocris, UK and applied via a
rapid bath perfusion system. Recordings of mIPSCs were
performed in continuous presence of APV 60 mM, CNQX
20 mM, CGP55845 1 mM, TTX 1 mM. GABA and glutamate
transporters were blocked by NCC-711 10 mM, TBOA 100 mM
and, DHK 300 mM as indicated in the respective results sections.
MeAIB (a-(Methyl-amino) isobutyric acid was obtained from
Sigma (Deisenhofen, Gemany) and added at 5 mM 5 min pior to
stimulation or at the respective time point for control cells. O-
(CNB-caged) GABA was obtained form Invitrogen, Germany and
was used at a final concentration of 20 mM.
Afferent Simulation
Increased network activity was simulated by afferent stimulation
performed for 1s @ 100 Hz in the presence of glutamatergic and
GABAB receptor blockers. A bipolar tungsten electrode was placed
upstream from the recorded cell at the inner border of the cell
body layer, approximately halfway between stratum pyramidale
and stratum radiatum. Initially, the strength of synaptic activation
was assessed in current clamp condition. In these conditions, we
applied consecutive stimuli with rising strength at intervals of 30 s.
The effective stimulation strength was adjusted to yield action
potentials in about 50% of trials in the postsynaptically recorded
CA1 pyramidal neuron. We then switched to voltage clamp
configuration and applied CNQX and APV to prevent conven-
tional mechanisms of synaptic plasticity through ionotropic
glutamate receptors. Immediately after the stimulus train, the
bath solution was supplemented with 1 mM TTX which reliably
suppressed action potentials within 20 s, enabling the isolation of
mIPSCs.
Laser photolysis
O-(CNB-caged) GABA, 20 mM was applied via bath perfusion.
UV-light for flash photolysis was generated by a frequency tripled
Nd:YAG laser (l=355 nm, 15 ns; Rapp OptoElectronic, Ham-
burg, Germany). Laser power was adjusted to 75% of its
maximum. UV light was delivered to the objective plane of the
microscope by an optical fiber and relayed through the 636water
immersion objective to form a spot of 2–3 mm. This spot was
targeted to the soma of the recorded cell. The laser was gated to
produce 15 ns long pulses which were used for photolysis of caged
GABA (20 mM; 10 pulses delivered with 20 s intervals). GABA
responses were stable during 10 subsequent applications at this
interval.
Data analysis
Currents were low-pass filtered at 3 kHz, digitally sampled at
20 kHz and analyzed offline (Spike/Signal, Cambridge Electron-
ics Design, UK; OriginLabs, OriginLab Corporation, USA).
mIPSC were identified by an automated event detection algorithm
based on templates. Reliability of detection criteria was assessed by
comparison with hand-evaluated individual traces. Effects on
amplitudes are indicated by comparison of median values. Results
from multiple cells are reported as mean6s.e.m. Statistical
Neuronal Plasticity
PLoS ONE | www.plosone.org 9 August 2008 | Volume 3 | Issue 8 | e2979comparisons were based on non-parametric tests, using the Mann-
Whitney-U test as not otherwise stated, a p-value,0.05 was
considered as significant.
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